Boehringer Ingelheim Pharmaceuticals, Inc. has voluntarily recalled 112 folding cartons of Mirapex (pramipexole dihydrochloride) 1 mg tablets because routine testing identified tablets that weighed less than required specifications. These 100-count unit-dose cartons were distributed nationwide across the United States. Consumers who have this medication should check their packaging for the specific lot number and expiration date to see if their medicine is affected. If you have used this product, you should contact your healthcare provider or pharmacist for further guidance.
Low weight tablets may not contain the full amount of active medication required for treatment, which could result in a patient receiving a lower dose than prescribed. This could potentially lead to a reduction in the drug's effectiveness for managing symptoms.
Healthcare provider consultation and pharmacy return
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.